Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Meningeal Neoplasms

• Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
• Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease
• Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
• Testing of the Anti Cancer Drugs CB-839 HCl (Telaglenastat) and MLN0128 (Sapanisertib) in Advanced Stage Non-small Cell Lung Cancer
• Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
• Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
• Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
• Pembrolizumab in Patients With Leptomeningeal Disease
• Intrathecal Mafosfamide
• DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
• S9624 Ifosfamide in Treating Patients With Meningeal Tumors
• Phase I Study of Intrathecal Topotecan
• Phase I Study of Intrathecal Mafosfamide